Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parasitic Diseases

  Free Subscription


Articles published in Parasite Immunol

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    September 2021
  1. SHEIKHI S, Khamesipour A, Radjabian T, Ghazanfari T, et al
    Immunotherapeutic Effects of Glycyrrhiza glabra and Glycyrrhizic Acid on Leishmania major Infected BALB/C Mice.
    Parasite Immunol. 2021 Sep 24:e12879. doi: 10.1111/pim.12879.
    PubMed     Abstract available


  2. DE FREITAS TELES L, Viana AG, Cardoso MS, Pinheiro GRG, et al
    Evaluation of medullary cytokine expression and clinical and laboratory aspects in severe human visceral leishmaniasis.
    Parasite Immunol. 2021 Sep 24:e12880. doi: 10.1111/pim.12880.
    PubMed     Abstract available


    August 2021
  3. KESHAV P, Goyal DK, Kaur S
    Antileishmanial potential of immunomodulator gallic acid against experimental murine visceral leishmaniasis.
    Parasite Immunol. 2021 Aug 4:e12875. doi: 10.1111/pim.12875.
    PubMed     Abstract available


    July 2021
  4. PACHECO DE ARAUJO ALBUQUERQUE , da Silva AM, de Araujo Batista FM, de Souza Sene I, et al
    The influence of sex hormones on the immune response to leishmaniasis.
    Parasite Immunol. 2021 Jul 26:e12874. doi: 10.1111/pim.12874.
    PubMed     Abstract available


    May 2021
  5. ZHENG L, Wang L, Hu Y, Yi J, et al
    Higher frequency of circulating Vdelta1 gammadeltaT cells in patients with advanced schistosomiasis.
    Parasite Immunol. 2021 May 26:e12871. doi: 10.1111/pim.12871.
    PubMed     Abstract available


  6. JAFARZADEH A, Nair A, Jafarzadeh S, Nemati M, et al
    Immunological role of keratinocytes in leishmaniasis.
    Parasite Immunol. 2021 May 24:e12870. doi: 10.1111/pim.12870.
    PubMed     Abstract available


    April 2021
  7. DARZI F, Davoudian R, Nateghi Rostami M
    Differential inflammatory responses associated with Leishmania major and L. tropica in culture.
    Parasite Immunol. 2021 Apr 29:e12841. doi: 10.1111/pim.12841.
    PubMed     Abstract available


    March 2021
  8. PRADHAN S, Ghosh S, Hussain S, Paul J, et al
    Linking membrane fluidity with defective antigen-presentation in leishmaniasis.
    Parasite Immunol. 2021 Mar 23:e12835. doi: 10.1111/pim.12835.
    PubMed     Abstract available


    February 2021
  9. PEREZ-MAZLIAH D, Ward AI, Lewis MD
    Host-parasite dynamics in Chagas disease from systemic to hyper-local scales.
    Parasite Immunol. 2021;43:e12786.
    PubMed     Abstract available


  10. HARES MF, Tiffney EA, Johnston LJ, Luu L, et al
    Stem cell-derived enteroid cultures as a tool for dissecting host-parasite interactions in the small intestinal epithelium.
    Parasite Immunol. 2021;43:e12765.
    PubMed     Abstract available


    January 2021
  11. CARABALLO-GUZMAN A, Ospina-Villa JD, Cuesta-Caicedo A, Sanchez-Jimenez MM, et al
    Immunoproteomics characterization of Leishmania panamensis proteins for potential clinical diagnosis of mucosal leishmaniasis.
    Parasite Immunol. 2021 Jan 23:e12824. doi: 10.1111/pim.12824.
    PubMed     Abstract available


  12. ZOU ZQ, Liu M, Zhong HQ, Guan GY, et al
    Association of previous schistosome infection with fatty liver and coronary heart disease: a cross-sectional study in China.
    Parasite Immunol. 2021 Jan 17:e12822. doi: 10.1111/pim.12822.
    PubMed     Abstract available


    December 2020
  13. MOHAMMADI AM, Duthie MS, Reed SG, Javadi A, et al
    Evolution of antigen-specific immune responses in cutaneous leishmaniasis patients.
    Parasite Immunol. 2020 Dec 22:e12814. doi: 10.1111/pim.12814.
    PubMed     Abstract available


    November 2020
  14. AGHAEI M, Khanahmad H, Aghaei S, Hosseini SM, et al
    Evaluation of transgenic Leishmania infantum expressing mLLO-BAX-SMAC in the apoptosis of the infected macrophages in vitro and in vivo.
    Parasite Immunol. 2020;42:e12726.
    PubMed     Abstract available


    October 2020
  15. HUSSAIN A, Ghosh S, Roy K, Nath S, et al
    A mushroom derived 'carbohydrate-fraction' reinstates host-immunity and protects from Leishmania donovani infection.
    Parasite Immunol. 2020 Oct 31:e12806. doi: 10.1111/pim.12806.
    PubMed     Abstract available


  16. DUTRA BM, de Castro Rodrigues NL, Fonseca FRM, de Moura TR, et al
    CXCL10 immunomodulatory effect against infection caused by an antimony refractory isolate of Leishmania braziliensis in mice.
    Parasite Immunol. 2020 Oct 31:e12805. doi: 10.1111/pim.12805.
    PubMed     Abstract available


  17. GONZALEZ K, Calzada JE, Tomokane TY, Sandoval Pacheco CM, et al
    In situ study of cellular immune response in human cutaneous lesions caused by Leishmania (Viannia) panamensis in Panama.
    Parasite Immunol. 2020 Oct 17. doi: 10.1111/pim.12801.
    PubMed     Abstract available


    September 2020
  18. LIMA SS, Braz DC, Silva VC, de Jesus Cardoso Farias Pereira T, et al
    Biomarkers of the early response to treatment of visceral leishmaniasis: a prospective cohort study.
    Parasite Immunol. 2020 Sep 27:e12797. doi: 10.1111/pim.12797.
    PubMed     Abstract available


  19. NATEGHI ROSTAMI M
    CRISPR/Cas9 gene drive technology to control transmission of vector-borne parasitic infections.
    Parasite Immunol. 2020;42:e12762.
    PubMed     Abstract available


  20. NAVA-CASTRO KE, Togno-Peirce C, Palacios-Arreola MI, Del Rio-Araiza VH, et al
    Bisphenol A induces protection through modulation of the immune response against the helminth parasite Taenia crassiceps.
    Parasite Immunol. 2020;42:e12733.
    PubMed     Abstract available


    August 2020
  21. MORAVEJ A, Choopanizadeh M, Pourabbas B, Pouladfar G, et al
    Treatment effects on IL-9+CD4+T cells and the cytokines influencing IL-9 production in pediatric visceral leishmaniasis.
    Parasite Immunol. 2020 Aug 18:e12787. doi: 10.1111/pim.12787.
    PubMed     Abstract available


  22. GUAN F, Zhang C, Jiang C, Lupemba Jacques M, et al
    ApoE deficiency promotes hepatic pathology by aggravating Th17/Treg imbalance in murine schistosomiasis japonica.
    Parasite Immunol. 2020 Aug 12:e12785. doi: 10.1111/pim.12785.
    PubMed     Abstract available


  23. PEREIRA IAG, Mendonca DVC, Tavares GSV, Lage DP, et al
    Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
    Parasite Immunol. 2020 Aug 9:e12784. doi: 10.1111/pim.12784.
    PubMed     Abstract available


  24. SILVA LP, Paciello MO, Aviz Teixeira WP, Rivas AV, et al
    Immunogenicity of HLA-DR1 and HLA-A2 peptides derived from Leishmania major Gp63 in golden hamsters.
    Parasite Immunol. 2020 Aug 1:e12780. doi: 10.1111/pim.12780.
    PubMed     Abstract available


    July 2020
  25. MOULIK S, Karmakar J, Joshi S, Dube A, et al
    Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.
    Parasite Immunol. 2020 Jul 31:e12783. doi: 10.1111/pim.12783.
    PubMed     Abstract available


  26. LLANWARNE F, Helmby H
    Granuloma formation and tissue pathology in Schistosoma japonicum versus Schistosoma mansoni infections.
    Parasite Immunol. 2020 Jul 21:e12778. doi: 10.1111/pim.12778.
    PubMed     Abstract available


  27. KIRIK FE, Ulger M, Tezcan Ulger S, Aslan G, et al
    Association of cytokine gene polymorphisms with susceptibility to cutaneous leishmaniasis in a Turkish population.
    Parasite Immunol. 2020 Jul 13:e12775. doi: 10.1111/pim.12775.
    PubMed     Abstract available


    June 2020
  28. FLORES GA, Sandoval Pacheco CM, Sosa Ochoa WH, Gomes C, et al
    Th17 lymphocytes in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi in Central America.
    Parasite Immunol. 2020 Jun 30:e12772. doi: 10.1111/pim.12772.
    PubMed     Abstract available


  29. SAINI S, Rai AK
    Hamster, a close model for visceral leishmaniasis: opportunities and challenges.
    Parasite Immunol. 2020 Jun 28:e12768. doi: 10.1111/pim.12768.
    PubMed     Abstract available


  30. KARIMI KAKH M, Golchin M, Kazemi Arababadi M, Daneshvar H, et al
    Application of the Leishmania infantum 21 kDa recombinant protein for the development of an immunochromatographic test.
    Parasite Immunol. 2020 Jun 26:e12770. doi: 10.1111/pim.12770.
    PubMed     Abstract available


  31. VILLANUEVA-LIZAMA LE, Cruz-Chan JV, Versteeg L, Teh-Poot CF, et al
    TLR4 agonist protects against Trypanosoma cruzi acute lethal infection by decreasing cardiac parasite burdens.
    Parasite Immunol. 2020 Jun 26:e12769. doi: 10.1111/pim.12769.
    PubMed     Abstract available


    May 2020
  32. PARODI C, Barrio A, Garcia Bustos MF, Gonzalez Prieto AG, et al
    B cell profile, B-cell activating factor concentration and IgG levels in human cutaneous and mucosal leishmaniasis.
    Parasite Immunol. 2020 May 27:e12759. doi: 10.1111/pim.12759.
    PubMed     Abstract available


  33. PANDEY SC, Kumar A, Samant M
    Genetically modified live attenuated vaccine: a potential strategy to combat visceral leishmaniasis.
    Parasite Immunol. 2020 May 17:e12732. doi: 10.1111/pim.12732.
    PubMed     Abstract available


  34. MISRA P, Tandon R, Basak T, Sengupta S, et al
    Purified Splenic amastigotes of Leishmania donovani-Immunoproteomic approach for exploring Th1 stimulatory polyproteins.
    Parasite Immunol. 2020 May 16:e12729. doi: 10.1111/pim.12729.
    PubMed     Abstract available


  35. KUMAR A, Pandey SC, Samant M
    A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis.
    Parasite Immunol. 2020 May 7:e12727. doi: 10.1111/pim.12727.
    PubMed     Abstract available


    April 2020
  36. HASBY SAAD MA, El-Anwar N
    Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double edged, but adjustable weapon.
    Parasite Immunol. 2020 Apr 27:e12724. doi: 10.1111/pim.12724.
    PubMed     Abstract available


  37. PESSENDA G, Santana da Silva J
    Arginase and its mechanisms in Leishmania persistence.
    Parasite Immunol. 2020 Apr 15:e12722. doi: 10.1111/pim.12722.
    PubMed     Abstract available


  38. ABU ALSHAMAT E, Kweider M, Abbady AQ
    Camel Nanobodies: Promising Molecular Tools Against Leishmaniasis.
    Parasite Immunol. 2020 Apr 6:e12718. doi: 10.1111/pim.12718.
    PubMed     Abstract available


  39. MAJUMDER N, Ganguly S, Ghosh AK, Kundu S, et al
    Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro.
    Parasite Immunol. 2020 Apr 5:e12719. doi: 10.1111/pim.12719.
    PubMed     Abstract available


    February 2020
  40. ISAAC-MARQUEZ AP, Lezama-Davila CM
    Cytokine regulation of female-macrophage resistance to Leishmania mexicana parasites. Role of IL-12p70.
    Parasite Immunol. 2020;42:e12685.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: